Dyax (DYAX) News Today → A new way to collect income from stocks (From DTI) (Ad) Free DYAX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAnokion SA: Anokion Strengthens its Senior Leadership with Promotions and New Appointmentfinanznachrichten.de - September 7 at 9:33 AMAnokion Strengthens its Senior Leadership with Promotions and New Appointmentfinance.yahoo.com - September 7 at 9:33 AMMost immigrants in West Virginia are from these countriesmsn.com - July 17 at 12:30 PMIs David Corenswet A Good Fit For Superman? Here's How /Film Readers Feelmsn.com - July 17 at 12:30 PMMost immigrants in Virginia are from these countriesmsn.com - July 17 at 7:29 AMCytophage Technologies Inc. Board of Directors Welcomes New Member and Board Advisorbenzinga.com - July 11 at 10:33 AMJanhvi and Khushi Kapoor shower love Boney Kapoor as he cooks breakfast for Anshulamsn.com - July 7 at 7:47 AMNext-Generation Antibody Therapeutics Market Price & News with Share Forecastmarketwatch.com - May 16 at 8:52 AMS-1: NutriBand Inc.marketwatch.com - May 12 at 1:42 AMKorro Strengthens Leadership Team with Appointment of Shelby Walker as General Counselfinance.yahoo.com - May 10 at 10:10 AMAstria Therapeutics, Inc. (NASDAQ:ATXS) Q4 2022 Earnings Call Transcriptinsidermonkey.com - March 24 at 9:13 AMNext-Generation Antibody Therapeutics Market Analysis: Understanding The Current State and Future Trends 2023-2028marketwatch.com - March 14 at 8:35 AMNext-Generation Antibody Therapeutics Market Outlook and Forecast to 2029 with Top Countries Datamarketwatch.com - March 13 at 7:06 AMNext Generation Antibody Therapeutics Market Size, Latest Trends, Share, Top Players, Revenue and Forecast 2028marketwatch.com - March 8 at 4:36 AMHOOPS RECAP: In UT’s first full game without Zakai Ziegler, Tennessee fails to hit a shot during the final six minutes of the game, loses to Auburn 79-70msn.com - March 4 at 10:00 PMNext-Generation Antibody Therapeutics Market Size, Analysis with Key Players having Regional Statistics and Application Forecast to 2028marketwatch.com - February 26 at 4:33 AMPeter Hotez on new COVID XBB1.5 variant: 'People are saying this will be mild. It's not mild'msn.com - January 11 at 12:29 PMDrug Giant Shire Snaps Up Biotech Dyax for $5.9 Billionthestreet.com - January 2 at 5:39 PMAstria Therapeutics: Tailwinds Building With Novel Treatment Paradigmseekingalpha.com - December 24 at 3:02 AMNoisy toys and hearing damage with Ascent Audiology & Hearingmsn.com - December 13 at 6:19 PMCommentary: There are those who get out of the water when there’s a shark, and those who get inmsn.com - November 28 at 12:15 PMInstagrammer shares how their tiny ‘kitchen composter’ makes food waste disappear: ‘Everyone needs one’msn.com - November 18 at 8:49 PMNo more deaths recorded in Bristolmsn.com - November 17 at 11:51 AMMartin Lewis says thousands being ripped off when it comes to savings ratesmsn.com - November 2 at 6:52 AMKalVista: Another Setback But The Key Value Driver Is Still In Placeseekingalpha.com - October 14 at 4:52 PMSpaceX Ground Control References "Mean Girls" During Astronaut Launchmsn.com - October 6 at 12:51 AMErik Ten Hag Has Reportedly Named Four Manchester United Players To Run His Dressing Roommsn.com - October 5 at 2:50 PMQ32 Bio, a Clinical Stage Biotechnology Company Focused on Therapeutics that Restore Immune Homeostasis, Announces CEO Transitionfinance.yahoo.com - September 20 at 4:18 PMDyax Corporation CEO Discusses Q3 2010 Results - Earnings Call Transcriptthestreet.com - September 2 at 11:38 PMGhulam Nabi Azad's resignation has EXPOSED Congress; will fight J&K polls alone: BJPmsn.com - August 29 at 4:41 AMFor ViroPharma, Acquisition Plan Is Paying Offthestreet.com - August 23 at 6:51 PMWest Pharmaceutical Services, Inc.marketwatch.com - May 2 at 1:07 AMGene Therapies & Associated Vectors Intellectual Property Landscape 2022 - ResearchAndMarkets.commorningstar.com - April 16 at 6:53 PM5 Biotech Stocks to Trade for Gainsthestreet.com - February 25 at 9:33 PMRhythm Pharmaceuticals Announces Promotions within its Executive Leadership Teamnz.finance.yahoo.com - February 23 at 11:51 AM4 Big Stocks on Traders' Radars: Buy, Sell or Hold?thestreet.com - January 21 at 10:12 PMSurface Oncology Appoints Denice Torres as Chair of the Board of Directorsapnews.com - December 15 at 7:42 AMFinch Therapeutics Announces the Appointment of Marc Blaustein as Chief Operating Officerau.finance.yahoo.com - September 8 at 8:24 AM Get Dyax News Delivered to You Automatically Sign up to receive the latest news and ratings for DYAX and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him DYAX Media Mentions By Week DYAX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DYAX News Sentiment▼0.000.45▲Average News Sentiment DYAX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DYAX Articles This Week▼00▲DYAX Articles Average Week Get Dyax News Delivered to You Automatically Sign up to receive the latest news and ratings for DYAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DYAX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyax Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
